Evidence map›Paper›PMID 32298263›Full record

ReviewPLoS neglected tropical diseases2020

Host immune responses during Taenia solium Neurocysticercosis infection and treatment.

Ulrich Fabien Prodjinotho, Jakobo Lema, Matthew Lacorcia, Veronika Schmidt, Nermina Vejzagic, Chummy Sikasunge, Bernard Ngowi, Andrea Sylvia Winkler, Clarissa Prazeres da Costa

Open access · goldAbstract readReview
In one paragraph

Review in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. In Vitro Evaluation of Esters of Quinoxaline-1,4-di-Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Ulrich Fabien ProdjinothoInstitute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), Munich, Germany.
Jakobo LemaMuhimbili Medical Research Centre, National Institute for Medical Research (NIMR), Dar es Salaam, Tanzania.
Matthew LacorciaInstitute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), Munich, Germany.
Veronika SchmidtDepartment of Neurology, Klinikum rechts der Isar, Technical University Munich (TUM), Munich, Germany.
Nermina VejzagicInstitute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), Munich, Germany.
Chummy SikasungeSchool of Veterinary Medicine, Department of Paraclinicals, University of Zambia, Lusaka, Zambia.
Bernard NgowiMuhimbili Medical Research Centre, National Institute for Medical Research (NIMR), Dar es Salaam, Tanzania.
Andrea Sylvia WinklerDepartment of Neurology, Klinikum rechts der Isar, Technical University Munich (TUM), Munich, Germany.
Clarissa Prazeres da CostaInstitute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), Munich, Germany.ORCID 0000-0001-7996-4838
Institute of Medical Microbiology and Hygiene · DEUniversity of Oslo · NONational Institute for Medical Research · TZUniversity of Dar es Salaam · TZUniversity of Zambia · ZM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Taenia solium cysticercosis and taeniasis (TSCT), caused by the tapeworm T. solium, is a foodborne and zoonotic disease classified since 2010 by WHO as a neglected tropical isease. It causes considerable impact on health and economy and is one of the leading causes of acquired epilepsy in most endemic countries of Latin America, Sub-Saharan Africa, and Asia. There is some evidence that the prevalence of TSCT in high-income countries has recently increased, mainly due to immigration from endemic areas. In regions endemic for TSCT, human cysticercosis can manifest clinically as neurocysticercosis (NCC), resulting in epileptic seizures and severe progressive headaches, amongst other neurological signs and/or symptoms. The development of these symptoms results from a complex interplay between anatomical cyst localization, environmental factors, parasite's infective potential, host genetics, and, especially, host immune responses. Treatment of individuals with active NCC (presence of viable cerebral cysts) with anthelmintic drugs together with steroids is usually effective and, in the majority, reduces the number and/or size of cerebral lesions as well as the neurological symptoms. However, in some cases, treatment may profoundly enhance anthelmintic inflammatory responses with ensuing symptoms, which, otherwise, would have remained silent as long as the cysts are viable. This intriguing silencing process is not yet fully understood but may involve active modulation of host responses by cyst-derived immunomodulatory components released directly into the surrounding brain tissue or by the induction of regulatory networks including regulatory T cells (Treg) or regulatory B cells (Breg). These processes might be disturbed once the cysts undergo treatment-induced apoptosis and necrosis or in a coinfection setting such as HIV. Herein, we review the current literature regarding the immunology and pathogenesis of NCC with a highlight on the mobilization of immune cells during human NCC and their interaction with viable and degenerating cysticerci. Moreover, the immunological parameters associated with NCC in people living with HIV/AIDS and treatments are discussed. Eventually, we propose open questions to understand the role of the immune system and its impact in this intriguing host-parasite crosstalk.

Indexed as

Immunity, CellularAnimalsAnthelminticsAnti-Inflammatory AgentsHost-Parasite InteractionsHumansNeurocysticercosisTaenia soliumAnthelminticsAnti-Inflammatory Agents

Identifiers

PMID32298263
PMCPMC7162612
OpenAlexW3016462748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.